Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Bausch & Lomb Corp | EVP of R&D and CMO | Common Shares, No Par Value | 102K | $1.68M | $16.47 | Mar 1, 2024 | Direct |
Bausch & Lomb Corp | EVP of R&D and CMO | Common Shares, No Par Value | 99.4K | $1.54M | $15.53 | Jul 25, 2024 | Direct |
Bausch & Lomb Corp | EVP of R&D and CMO | Non-Qualified Stock Options (right to purchase) | 63.5K | Feb 28, 2024 | Direct | ||
APPLIED GENETIC TECHNOLOGIES CORP | Director | Stock Option (Right to Buy) | 0 | Nov 30, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BLCO | Bausch & Lomb Corp | Jul 25, 2024 | 1 | -$44.1K | 4 | Jul 29, 2024 | EVP of R&D and CMO |
BLCO | Bausch & Lomb Corp | Mar 1, 2024 | 1 | -$35.3K | 4 | Mar 4, 2024 | EVP of R&D and CMO |
BLCO | Bausch & Lomb Corp | Feb 28, 2024 | 2 | $0 | 4 | Mar 1, 2024 | EVP of R&D and CMO |
BLCO | Bausch & Lomb Corp | Jul 25, 2023 | 1 | -$79.2K | 4 | Jul 27, 2023 | EVP of R&D and CMO |
BLCO | Bausch & Lomb Corp | Mar 1, 2023 | 2 | $0 | 4 | Mar 3, 2023 | EVP, R&D and CMO |
AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Nov 30, 2022 | 2 | $0 | 4 | Dec 1, 2022 | Director |
BLCO | Bausch & Lomb Corp | Jul 25, 2022 | 1 | $0 | 4 | Jul 27, 2022 | EVP, R&D and CMO |
BLCO | Bausch & Lomb Corp | May 5, 2022 | 2 | $0 | 4 | May 9, 2022 | EVP, R&D and CMO |
BLCO | Bausch & Lomb Corp | May 5, 2022 | 0 | $0 | 3 | May 5, 2022 | EVP, R&D and CMO |
AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Nov 30, 2021 | 1 | $0 | 4 | Dec 2, 2021 | Director |
AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Aug 16, 2021 | 1 | $0 | 4 | Aug 18, 2021 | Director |
AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Aug 16, 2021 | 0 | $0 | 3 | Aug 18, 2021 | Director |